Compare MLM & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLM | CNC |
|---|---|---|
| Founded | 1993 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.4B | 33.1B |
| IPO Year | 1996 | 2001 |
| Metric | MLM | CNC |
|---|---|---|
| Price | $477.98 | $65.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 21 |
| Target Price | ★ $635.17 | $71.78 |
| AVG Volume (30 Days) | 759.5K | ★ 3.1M |
| Earning Date | 11-03-2026 | 10-27-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 29.27 | 5.30 |
| Revenue | $6,150,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $27.17 | $11.22 |
| Revenue Next Year | $23.04 | N/A |
| P/E Ratio | $16.45 | ★ $12.18 |
| Revenue Growth | N/A | ★ 19.44 |
| 52 Week Low | $470.19 | $31.63 |
| 52 Week High | $710.97 | $69.63 |
| Indicator | MLM | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 38.57 | 56.06 |
| Support Level | $470.19 | $62.98 |
| Resistance Level | $636.33 | $68.67 |
| Average True Range (ATR) | 12.10 | 1.82 |
| MACD | 1.10 | 0.33 |
| Stochastic Oscillator | 21.07 | 80.45 |
Martin Marietta is a leading US producer of construction aggregates, having produced roughly 200 million tons in 2025. Its aggregate reserves represent approximately 85 years of supply at 2025 production levels. Over the past several years, the company has increased its exposure to aggregates while reducing its presence in cement and downstream businesses such as concrete and asphalt. More recently, Martin Marietta expanded into an aggregate-adjacent business through its acquisition of Lhoist North America, the largest US producer of lime. The company operates across 28 states, with smaller operations in Canada and the Bahamas.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.